Published On : 2016-11-24
Increasing susceptibility towards incurable diseases has triggered an upheaval, prompting the healthcare sector to invigorate their research and development activities. Peptides have received the attention of researchers for their efficacy in treating and managing a wide range of diseases. Through scientific research done on peptides, it has been proven that peptides present in biologically in any living organism play an important role in its immunity from general diseases. Being an integral part of immunomodulatory activities taking place inside any life form makes peptide a vital as well as a beneficent medical constituent.
This fundamental merit of peptides has helped researchers shed light on different ways that define its significant applicability in medical therapies. The global peptide therapeutics market was valued at US$ 16 Bn in 2014. The steady rise in awareness on peptides and its therapeutic uses has created a great platform for gaining investments for its R&D. Surging growth of the global peptide therapeutics market indicates that the need for future research is evolving.
Advancements in peptide therapeutics will generate new growth opportunities in the global market. Findings from future research projects will benefit thehealthcare sector at a broader level.
Scope for Research in Peptide Therapeutics
While the end-results of any developments in peptide therapeutics are likely to be greatly beneficial, it is important to anticipate and keep a track on the factors that will prompt extensive research in the future. A key factor that will drive major R&D work in peptide therapeutics is its effectiveness in treating cancer. Based on the range of applicability of peptide therapeutics, its use in cancer surgeries and treatments has generated revenues that have recorded the highest market share of global peptide therapeuticsmarket at present. Use of peptide therapeutics in treating ovarian, breast, prostate and pancreatic cancer will incite more medical research in the future.
Therapeutic potential of antimicrobial peptides (AMP) is another key factor widening the scope of research in peptide therapeutics. The peptide therapeutics market will be exposed to a plethora of new growth opportunities derived from applications based on the research on antimicrobial peptides. AMPs are most commonly known as host defence peptides, and can be used as an alternate therapeutic agent for antibiotics. Advanced clinical applications in innate immune responses, bacterial resistance and bioinformatics will need in-depth research on AMPs, which will cater towards the rising need for research in peptide therapeutics.
Chemical instability, patent expiries, short half-life and less oral efficacy are some of the most prevalent challenges in peptide therapeutics landscape. Other factors that will expand the R&D work on peptides include low oral bioavailability, increasing FDI, and ever-growing global healthcare expenditure.
Future of Peptide Therapeutics
It is a strongly likelihood that most of the developments derived from ongoing as well as upcoming research will prove profitable for peptide therapeutics market. But, it is important for clinical researchers and scientist to identify some developments that may cause harm to the patients being treated with peptide therapy. Forums like the Peptide Therapeutics Symposium are held annually, so that global leaders in peptide research can meet and discuss the efficiency of peptide-based drugs as well as the future of pharmaceutical companies manufacturing them.
During the forecast period 2016-2026, the global peptide therapeutics market is expected to increase at 10% CAGR. North America will dominate as the largest market, and along with Europe and Latin America will account for nearly 75% revenue share of the market. Companies like Bachem Holding AG, AstraZeneca plc, CordenPharma International GmbH, Ipsen S.A, Novo Nordisk A/S and PolyPeptide Group are shaping up the competitive landscape of global peptide therapeutics market. Besides increasing manufacturing capacity, these key players are providing industrial space and capital to begin groundwork for research.